title: Colistin and rifampicin combination in the treatment of ventilator-associated pneumonia caused by carbapenem-resistant Acinetobacter baumannii.
authors.forename: Joon Young
authors.initials: JY
authors.lastname: Song
authors.forename: Jacob
authors.initials: J
authors.lastname: Lee
authors.forename: Jung Yeon
authors.initials: JY
authors.lastname: Heo
authors.forename: Ji Yun
authors.initials: JY
authors.lastname: Noh
authors.forename: Woo Joo
authors.initials: WJ
authors.lastname: Kim
authors.forename: Hee Jin
authors.initials: HJ
authors.lastname: Cheong
authors.forename: In Sook
authors.initials: IS
authors.lastname: Hwang
mesh_terms: D000151:Acinetobacter Infections / Q000188:drug therapy* / Q000382:microbiology; D040981:Acinetobacter baumannii / Q000187:drug effects*; D000328:Adult; D000368:Aged; D000900:Anti-Bacterial Agents / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D015780:Carbapenems / Q000494:pharmacology*; D003091:Colistin / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D024881:Drug Resistance, Bacterial; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D008297:Male; D008826:Microbial Sensitivity Tests; D008875:Middle Aged; D053717:Pneumonia, Ventilator-Associated / Q000188:drug therapy* / Q000382:microbiology; D012293:Rifampin / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D016896:Treatment Outcome
chemical_list: D000900:Anti-Bacterial Agents; D015780:Carbapenems; D012293:Rifampin; D003091:Colistin